JOHNSON & JOHNSON (NYSE:JNJ) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 11, 2026. The Healthcare company reported annual revenue…
JOHNSON & JOHNSON (NYSE:JNJ) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 11, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
JOHNSON & JOHNSON's stock currently trades at $240.86 with a market capitalization of $505.8B.
Current market data
NYSE · JNJ
$271.22
Up: +$0.54 · +0.20%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
